This nitrite reductase activity has been proposed to play a key role in the benefits of targeting the non-canonical pathway for nitric oxide (NO) generation in the cardiovascular disease setting; an effect specifically attributed to XOR-dependent recovery of NO levels. The gene discussed is NGB; the disease is cardiovascular disorder.